FindTrial
Sign In

DCE MRI

PROCEDURE6 trials

Sponsors

Stanford University, Yonsei University, John Hays, Asan Medical Center, Fudan University

Conditions

Advanced Adult Hepatocellular CarcinomaCarcinoma, Renal CellColorectal CancerKidney (Renal Cell) CancerKidney NeoplasmsMetastatic Liver CancerMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum

Phase 2

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
CompletedNCT01652196
John HaysMucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon +3
Start: 2012-11-14End: 2022-08-30Updated: 2025-02-05

Unknown Phase

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
CompletedNCT00537056
Stanford UniversityCarcinoma, Renal Cell, Kidney Neoplasms, Kidney (Renal Cell) Cancer
Start: 2007-10-31End: 2012-04-30Updated: 2017-06-14
Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis Patients
CompletedNCT01318239
Yonsei UniversityColorectal Cancer
Start: 2010-07-31End: 2013-04-30Updated: 2014-03-05
Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers
NCT01336452
Yonsei UniversityAdvanced Adult Hepatocellular Carcinoma
Start: 2011-04-30End: 2013-12-31Target: 30Updated: 2013-06-04
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
CompletedNCT02201797
Asan Medical CenterMetastatic Liver Cancer
Start: 2014-10-31End: 2015-06-30Updated: 2015-06-24
Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Not yet recruitingNCT06525415
Fudan UniversityPerfusion, Peripheral Arterial Disease
Start: 2024-08-01End: 2024-11-30Target: 30Updated: 2024-07-29